Bausch Health Companies Inc (BHC)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NYSE
Market Cap: $3.13B
Last updated: Nov 17, 2026 at 11:05 AM ET
Bausch Health Companies Inc (BHC) P/E Ratio & Valuation History
Bausch Health Companies (BHC) trades at 1.7x trailing earnings and 0.3x sales. Its P/E of 1.7x is below its 5-year median of 2.0x. Its forward P/E is 1.9x. The median P/E across 10 similar companies is 11.7x.
Current Multiples
Its forward P/E is above its trailing P/E, which implies earnings per share about 10.5% lower over the next year. Its free cash flow yield is 59.0%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 1.7x |
| Forward P/E | 1.9x |
| Price to sales | 0.3x |
| EV/EBITDA | 8.7x |
| Price to FCF | 1.7x |
| EV/FCF | 11.4x |
| PEG | N/A |
| FCF yield | 59.0% |
Historical Medians
Against its 10-year medians, its P/E is 41.4% below 2.9x and its P/S is 40.0% below 0.5x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 1.7x | 2.0x | 2.9x |
| P/S | 0.3x | 0.3x | 0.5x |
Valuation History
Over the 10 year ends shown, its P/E ranged from 1.8x in 2025 to 6.7x in 2019. 2025 was the lowest of those years.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $6.95 | 1.8x | 0.3x | N/A |
| 2024 | $8.06 | 2.1x | 0.3x | N/A |
| 2023 | $8.02 | 2.3x | 0.3x | N/A |
| 2022 | $6.28 | 2.1x | 0.3x | N/A |
| 2021 | $27.61 | 6.2x | 1.2x | N/A |
| 2020 | $20.80 | 5.2x | 107.2x | 14.0x |
| 2019 | $29.92 | 6.7x | 1.2x | 10.1x |
| 2018 | $18.47 | 4.6x | 0.8x | 2.4x |
| 2017 | $20.78 | 5.4x | 0.8x | 1.3x |
| 2016 | $14.52 | 2.6x | 0.5x | 1.6x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About BHC
What is BHC's forward P/E ratio?
Bausch Health Companies has a forward P/E ratio of 1.9x.
Is BHC stock overvalued?
GNG's valuation label for BHC is Undervalued. Its P/E of 1.7x compares with a median of 11.7x across 10 similar companies.
What is BHC's price to sales ratio?
Bausch Health Companies has a price to sales ratio of 0.3x.
What is Bausch Health Companies's average P/E ratio over 5 years?
Bausch Health Companies's median P/E over the last 5 years is 2.0x, from 60 month-end values through Oct 2026.
BHC pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors